Parse Biosciences
Parse Biosciences provides scalable, instrument-free single cell sequencing solutions and services for researchers, enabling whole transcriptome profiling and paired receptor sequencing across large numbers of cells and samples. Its end-to-end workflow includes sample fixation, barcoding, library preparation, sequencing, and streamlined data analysis through its software platform. The organization aims to make single cell research accessible and efficient to accelerate scientific discovery.
Facts
- HQ
- Seattle, WA 98109
- Sectors
- Biotechnology Research
- Founded
- 2018
- Type
- Corporation Seattle business license
- Employees
- 148
- Registered name
- Parse Biosciences Inc Seattle business license
- Stage
- Series C
Is this your organization? Claim it
Seattle’s UW research, Amazon alumni and military adjacency fuel startups building high-stakes, regulation-ready AI for biotech, finance and government
A Seattle high-school intern argues that strict school AI rules illuminated why AI must be disciplined in high-stakes domains, and describes how Seattle's research institutions (notably UW and the David Baker ecosystem), Amazon alumni, and military adjacency produce founders building accountable, regulation-ready AI for biotech, finance, and government.
Qiagen to Acquire Seattle’s Parse Biosciences for $225 Million in Cash Deal Closing December 2023
Seattle's Parse Biosciences, a single-cell RNA sequencing company founded in 2018, is being acquired by Netherlands-based Qiagen in a $225 million cash deal expected to close in December. Parse, which serves 3,000 customers globally and raised over $50 million in funding, will continue operating from its Seattle headquarters as a Qiagen subsidiary.
GeekWire returns in person for 2022 Awards at Showbox SoDo, honoring 60+ finalists across 15 categories with 16,000+ votes
GeekWire held its first in-person GeekWire Awards in three years at Showbox SoDo in Seattle, honoring 60+ finalists across 15 categories with over 16,000 community votes and appearances by local tech leaders and entertainers.
By Parse Biosciences
Split Biosciences Awarded NSF SBIR Grant to Fund R&D
Split Biosciences received an SBIR grant from the National Science Foundation to provide seed funding for research and development.
People
-
Alex Rosenberg Co-founder, CEO and Cofounder
-
Charles Roco Co-founder, CTO and Cofounder
Online
Questions about Parse Biosciences
What is Parse Biosciences?
Parse Biosciences provides scalable, instrument-free single cell sequencing solutions and services for researchers, including whole transcriptome profiling and paired receptor sequencing. Its workflow spans sample fixation, barcoding, library preparation, sequencing and software-based data analysis.
What has Parse Biosciences been in the news for?
GeekWire reported in November 2025 that Qiagen would acquire Seattle’s Parse Biosciences.
Who are the people behind Parse Biosciences?
Alex Rosenberg is CEO and co-founder of Parse Biosciences. Charles Roco is CTO and co-founder.
Who invested in Parse Biosciences, and how much has it raised?
Members of Seattle Flow see Parse Biosciences' funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Parse Biosciences based?
Parse Biosciences is based in Seattle, WA 98109.
When was Parse Biosciences founded?
Parse Biosciences was founded in 2018.